MOA-728 (methylnaltrexone)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MOA-728 (methylnaltrexone), covering 2020-01-02 to 2020-01-02. Get the full timeline:
Most recent: Clinical Trial Update: Study Evaluating the Efficacy and Safety of Subcutaneous Methylnaltrexone (MOA-728) for the Treatment of Opioid-Induced-Constipation [Phase 3]